gimeracil +oteracil +tegafur +folinic acid (TAS-118) / Otsuka  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
gimeracil +oteracil +tegafur +folinic acid (TAS-118) / Otsuka
SOLAR, NCT02322593: Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer

Completed
3
711
Japan, RoW
TAS-118 plus Oxaliplatin, S-1 plus Cisplatin
Taiho Pharmaceutical Co., Ltd., Yakult Honsha Co., LTD
Gastric Cancer
02/19
05/20

Download Options